Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Treatment of methotrexate (MTX...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX

Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX

Bibliographic Details
Main Authors: Wulffraat NM, Rademaker C, Sinnema G, Bulatović M, Verkaaik M
Format: Article
Language:English
Published: BMC 2011-09-01
Series:Pediatric Rheumatology Online Journal
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World
    by: Zhang L, et al.
    Published: (2020-12-01)
  • How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?—MTX in the Treat-to-Target Strategy
    by: Peter. C. Taylor, et al.
    Published: (2019-04-01)
  • The GO-DACT protocol: a multicentre, randomized, double-blind, parallel-group study to compare the efficacy of golimumab in combination with methotrexate (MTX) versus MTX monotherapy
    by: Elsa Vieira-Sousa, et al.
    Published: (2018-04-01)
  • Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy
    by: Jing Zhang, et al.
    Published: (2020-10-01)
  • Outcome von Patienten mit primärem ZNS-Lymphom PCNSL) unter primärer Chemotherapie mit Methotrexat + Ifosfamid (MTX/IFO) versus MTX/IFO + Rituximab (R-MTX/IFO) unter Verzicht auf eine adjuvante Ganzhirnbestrahlung
    by: Stadler, Elisabeth Anne
    Published: (2013)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...